Ainos (AIMD) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
9 Apr, 2026Market opportunity and vision
Smell is identified as the missing data layer in AI, with current AI systems lacking olfactory data integration.
Digitizing smell into data (Smell ID) creates a new opportunity for AI to interpret and utilize scent information.
SmellTech-as-a-Service is positioned as a scalable, recurring revenue model combining hardware and AI.
Technology and platform
AI Nose system detects trace odors at ppb-level sensitivity with real-time response and multi-sensor fusion.
Smell Language Model (SLM) contextualizes Smell ID using deep learning and a scent database.
Cloud-based management enables remote monitoring and multi-site deployment.
Industry applications and partnerships
Initial focus on smart manufacturing, where early scent detection improves yield and efficiency.
Secured a 1,400-unit, $2.1M, 3-year deployment in semiconductor factories, with a roadmap up to 20,000 units.
Partnerships with TSC and Trusval expand access to chip manufacturing and fab infrastructure, with minimum commitments for hundreds of units.
Collaboration with MiRLE enables robots and robotic dogs to detect hazardous environments and support security and inspection.
Latest events from Ainos
- 499% revenue growth in 2025 and strong gross margin signal momentum for AI Nose in 2026.AIMD
Q4 202530 Mar 2026 - AI Nose is scaling as an AI perception platform, targeting industrial and robotics growth in 2026.AIMD
Fireside chat2 Feb 2026 - Secondary offering of 6.7M shares enables liquidity for stockholders, no proceeds to company.AIMD
Registration Filing16 Dec 2025 - Registration enables resale of 6.7M+ shares from various agreements and awards.AIMD
Registration Filing16 Dec 2025 - Shareholders will vote on auditor ratification, special stock awards, and meeting adjournment.AIMD
Proxy Filing2 Dec 2025 - Annual meeting to vote on directors, auditor, special stock awards, and key governance matters.AIMD
Proxy Filing2 Dec 2025 - Votes sought for auditor ratification and 2 million special stock awards at September 2024 meeting.AIMD
Proxy Filing2 Dec 2025 - AI Nose commercialization and cost reductions narrowed Q3 2025 net loss as revenue grew.AIMD
Q3 202513 Nov 2025 - AI Nose rollout drove first revenues, a $2.1M order, and positive gross margin despite wider losses.AIMD
Q2 202513 Aug 2025